Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8638)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2024 (publication date) through Dec 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Cao WH, Zhang YQ, Li XX, Zhang ZY, Li MH. Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients. World J Hepatol 2024; 16(10): 1158-1168 [PMID: 39474576 DOI: 10.4254/wjh.v16.i10.1158] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Cao WH, Zhang YQ, Li XX, Zhang ZY, Li MH. Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients. World J Hepatol 2024; 16(10): 1158-1168 [PMID: 39474576 DOI: 10.4254/wjh.v16.i10.1158] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i10/1158.htm |
| Number | Citing Articles |
| 1 |
Onur Baş, Leyla Sert, Onur Yazdan Balçık, Mert Tokatli, Nur Evşan Boyraz, Gözde Kavgaci, Taha Koray Şahin, Deniz Can Güven, Zafer Arık, Abdurrahman Işikdoğan, Mustafa Erman. Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country. Expert Review of Anticancer Therapy 2025; 25(10): 1213 doi: 10.1080/14737140.2025.2529290
|
| 2 |
Yuyao Yuan, Donghao Yin, Xuemeng Yang, Di Liu, Hui Shan, Juan Luo, Xiuhui Li, Yuxin Yin. Plasma lipidomic analysis reveals disruption of ether phosphatidylcholine biosynthesis and facilitates early detection of hepatitis B-related hepatocellular carcinoma. Lipids in Health and Disease 2025; 24(1) doi: 10.1186/s12944-025-02475-z
|
| 3 |
Zixuan Wang, Guangji Zhang. Anti-tumor effects of GPC3 CAR-iNKT cells in murine models of hepatocellular carcinoma. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-025-11263-y
|
| 4 |
Yuzhen Huang, Ni Yang, Su Wen, Ziwei Fang, Yucong Zhang, Zonghao Qian, Yi Huang, Tiejun Yin, Cuntai Zhang, Le Zhang. Overexpression of ORAOV1 and its association with immunotherapy resistance in hepatocellular carcinoma. PeerJ 2025; 13: e20390 doi: 10.7717/peerj.20390
|
| 5 |
Christina Karampera, Antonio D'Alessio. Not So Quiet on the Viral Front: Low‐Level HBV Viraemia Undermines Immunotherapy in HCC. Liver International 2025; 45(6) doi: 10.1111/liv.70140
|